Clinical trial
Hormone Therapy in Treating Patients With Advanced Prostate Cancer
NCT00003026 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003026 |
|---|---|
| Title | Hormone Therapy in Treating Patients With Advanced Prostate Cancer |
| Official title | Long Term Adjuvant Hormonal Treatment With LHRH Analogue Versus No Further Treatment in Locally Advanced Prostatic Carcinoma Treated by External Irradiation and a Six Months Combined Androgen Blockade - A Phase III Study |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | bicalutamide, flutamide, triptorelin, radiation therapy |
| Enrollment | 966 |
| Start date | Apr 1, 1997 |
| Primary completion | Sep 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 2, 2012 |
| Countries | Belgium, Israel, Malta, Netherlands, Russia, Turkey (Türkiye), United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: